Related Experiment Video
Updated: Aug 7, 2026
08:49
Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
Published on: August 2, 2024
N-terminal pro-B-type natriuretic peptide levels in acute versus chronic left ventricular dysfunction
Iris Fried1, Benjamin Bar-Oz, Zeev Perles
1Department of Pediatrics, Hadassah-The Hebrew University Medical Center, Jerusalem, Israel.
The Journal of Pediatrics
|July 25, 2006
Summary
Acute left ventricular dysfunction (LVD) causes significantly higher N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in children compared to chronic LVD. These elevated NT-proBNP levels in acute LVD indicate a distinct biomarker response in pediatric heart conditions.
Area of Science:
- Pediatric Cardiology
- Biomarkers in Heart Failure
- Clinical Diagnostics
Background:
- Left ventricular dysfunction (LVD) is a critical condition in pediatric heart disease.
- N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a key biomarker for cardiac stress.
- Differentiating acute from chronic LVD is crucial for effective management.
Purpose of the Study:
- To compare NT-proBNP levels in pediatric patients with acute LVD versus chronic LVD.
- To investigate the diagnostic utility of NT-proBNP in acute pediatric LVD.
Main Methods:
- Measured plasma NT-proBNP levels in pediatric patients with acute LVD, chronic dilated cardiomyopathy (DCM), and acute heart failure exacerbations.
- Utilized Mann-Whitney and ANOVA for rank tests for statistical comparison.
- Analyzed serial NT-proBNP measurements in patients with acute LVD.
Main Results:
- Significantly higher NT-proBNP levels observed in acute LVD (median 65,600 pg/mL) compared to chronic DCM (median 1125 pg/mL; P < .0001).
- NT-proBNP levels decreased in most patients with acute LVD over time.
- Levels in acute exacerbations were lower than in acute LVD (median 7185 pg/mL; P < .003).
Conclusions:
- Acute LVD in children is strongly associated with markedly elevated NT-proBNP levels.
- NT-proBNP serves as a valuable marker for identifying acute cardiac events in pediatric patients.
- The findings highlight the distinct biomarker profile of acute versus chronic pediatric LVD.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...